References
- Uraoka Y, Tanigawa T, Watanabe K, Machida H, Okazaki H, Yamagami H, et al. Complete remission of protein-losing gastroenteropathy associated with Sjögren's syndrome by B cell-targeted therapy with rituximab. Am J Gastroenterol. 2012; 107(8):1266–8.
- Nagashima T, Hoshino M, Shimoji S, Morino N, Kamimura T, Okazaki H, Minota S. Protein-losing gastroenteropathy associated with primary Sjögren's syndrome: a characteristic oriental variant. Rheumatol Int. 2009;29(7):817–20.
- Hsieh TY, Lan JL, Chen DY. Primary Sjögren's syndrome with protein-losing gastroenteropathy: report of two cases. J Formos Med Assoc 2002;101(7):519–22.
- Mok MY, Lau CS.Protein losing enteropathy and primary Sjögren's syndrome. Clin Exp Rheumatol. 1997;15(16):705.
- Tsutsumi A, Sugiyama T, Matsumura R, Sueishi M, Takabayashi K, Koike T, et al. Protein losing enteropathy associated with collagen diseases. Ann Rheum Dis. 1991;50(3):178–81.
- Nasu T, Miyata K, Uno A, Kawashima A, Kondo M, Akamizu T, Nakao T. Successful treatment of protein-losing gastroenteropathy with steroid pulse and immunosuppressive therapies in a patient with sjögren syndrome. Case Rep Gastroenterol. 2011;5(2):372–7.
- Nakajima A, Ohnishi S, Mimura T, Kubo K, Suzuki A, Yazaki Y, Matsuhashi S. Protein-losing enteropathy associated with hypocomplementemia and anti-nuclear antibodies. J Gastroenterol 2000;35(8):627–30.
- Furuya T, Suzuki T, Onoda N, Tamura K, Sato K, Demura H, Kashiwazaki S. Mixed connective tissue disease associated with protein losing enteropathy: successful treatment with intravenous cyclophosphamide therapy. Intern Med. 1992;31(12):1359–62.